II
ADMA icon

Inspire Investing’s ADMA Biologics ADMA Stock Holding History

Inspire Investing’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$508K Buy
56,398
+30,722
+120% +$485K 0.03% 824
2025
Q4 		$468K Sell
25,676
-5,638
-18% -$95K 0.04% 477
2025
Q3 		$459K Buy
31,314
+10,132
+48% +$174K 0.04% 392
2025
Q2 		$386K Buy
21,182
+3,742
+21% +$76.3K 0.04% 701
2025
Q1 		$346K Sell
17,440
-6,051
-26% -$105K 0.04% 380
2024
Q4 		$403K Sell
23,491
-41,176
-64% -$775K 0.05% 428
2024
Q3 		$1.29M Buy
64,667
+32,645
+102% +$508K 0.13% 159
2024
Q2 		$358K Sell
32,022
-157,281
-83% -$1.32M 0.04% 373
2024
Q1 		$1.25M Buy
189,303
+105,256
+125% +$575K 0.13% 195
2023
Q4 		$380K Sell
84,047
-2,276
-3% -$8.42K 0.04% 769
2023
Q3 		$309K Sell
86,323
-62,663
-42% -$241K 0.04% 443
2023
Q2 		$550K Sell
148,986
-14,196
-9% -$52.6K 0.07% 279
2023
Q1 		$540K Buy
+163,182
New +$564K 0.07% 215

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Inspire Investing's ADMA Position: Q1 2026 in Review

Inspire Investing increased its ADMA Biologics (ADMA) stake by 120% in Q1 2026, buying an estimated $485K and bringing the position to 56,398 shares worth $508K. The position accounts for 0.03% of the portfolio, ranked #824.

Inspire Investing first reported a position in ADMA in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.29M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Inspire Investing held 56,398 shares of ADMA Biologics worth $508K as of Q1 2026.
  • Inspire Investing bought 30,722 ADMA Biologics shares in Q1 2026, an estimated $485K.
  • ADMA Biologics made up 0.03% of Inspire Investing's portfolio in Q1 2026, its #824 holding.
  • Inspire Investing first reported a position in ADMA Biologics in Q1 2023 and has held it in 13 quarters since.
  • Inspire Investing's ADMA Biologics position peaked at $1.29M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.